13F Holdings
中文EN

UFPT UFP TECHNOLOGIES INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 914156 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.6%
TTM net income YoY14.0%
TTM EPS YoY13.7%
Revenue 3-yr CAGR18.6%
Net income 3-yr CAGR22.4%

Margins

Gross margin28.9%
Operating margin15.5%
Net margin11.8%
FCF margin—
EBITDA margin18.5%

Returns

ROE17.2%
ROA11.5%
ROIC (approx.)15.0%
Asset turnover0.97x

Leverage & solvency

Liabilities / assets28.8%
Debt / equity0.20x
Current ratio2.98x
Interest coverage14.64x

Cash quality & payout

Operating cash flow / net income0.97x
Accruals ratio0.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$602.80M$504.42M$400.07M$353.79M$206.32M
Cost of revenue$432.39M$357.73M$287.85M$263.53M$155.21M
Gross profit$170.41M$146.69M$112.22M$90.26M$51.11M
R&D expense$8.60M$10.40M$7.20M$9.30M$8.50M
SG&A expense$77.44M$62.22M$50.89M$45.80M$29.48M
Operating income$92.34M$80.90M$57.66M$55.40M$21.22M
Interest expense$9.80M$8.06M$3.65M$2.76M$39,000
Pretax income$82.51M$73.03M$53.90M$52.72M$21.20M
Income tax$14.20M$14.04M$8.98M$10.93M$5.32M
Net income$68.31M$58.98M$44.92M$41.79M$15.89M
EBITDA$111.49M$95.61M$69.07M$67.29M$29.63M
EPS (basic)8.877.695.895.522.11
EPS (diluted)8.757.585.835.452.09
Weighted avg. shares (diluted)7.80M7.79M7.70M7.66M7.62M
Balance sheet
Cash & equivalents$20.30M$13.45M$5.26M$4.45M$11.12M
Receivables$82.91M$84.68M$64.45M$55.12M$39.38M
Inventory$86.86M$87.54M$70.19M$53.54M$33.44M
Current assets$201.00M$194.94M$144.63M$116.35M$87.32M
PP&E, net$79.11M$70.56M$62.14M$58.07M$56.57M
Goodwill$197.40M$189.66M$113.26M$113.03M$107.91M
Intangibles$140.85M$144.25M$64.12M$68.36M$67.58M
Total assets$655.08M$629.00M$404.14M$378.19M$334.13M
Current liabilities$74.86M$76.30M$58.21M$55.96M$38.78M
Short-term debt$12.50M$12.50M$4.00M$4.00M$4.00M
Long-term debt$122.95M$176.88M$28.00M$51.00M$71.00M
Total debt$135.46M$189.38M$32.00M$55.00M$75.00M
Total liabilities$231.20M$286.24M$118.05M$140.65M$139.69M
Shareholders' equity$423.88M$342.76M$286.09M$237.54M$194.45M
Net debt$115.15M$175.93M$26.74M$50.55M$63.88M
Shares outstanding7.71M7.68M7.64M7.64M7.58M
Cash flow statement
Operating cash flow$91.91M$66.59M$41.33M$17.74M$14.29M
Capital expenditure—$9.66M$10.49M$13.78M$5.39M
Free cash flow—$56.94M$30.84M$3.96M$8.90M
Investing cash flow-$27.60M-$210.16M-$10.49M$1.29M-$101.46M
Financing cash flow-$58.16M$152.39M-$30.02M-$25.89M$74.05M
Depreciation & amortization$19.15M$14.71M$11.41M$11.89M$8.41M
Stock-based compensation$8.85M$6.84M$4.64M$3.21M$2.43M

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.